A Patient Decision Aid for Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Development and Pilot Study.
Kim Paul de CastroHarold Henrison Chang ChiuRonna Cheska De Leon-YaoLorraine Almelor-SembranaAntonio Miguel DansPublished in: JMIR cardio (2021)
Our study showed that an app-based PDA for anticoagulation therapy in patients with nonvalvular AF (1) reduced patient decisional conflict, (2) improved patient knowledge, and (3) was acceptable to patients and physicians. A PDA is potentially acceptable and useful in our setting. A randomized controlled trial is warranted to test its effectiveness compared to usual care. PDAs for other conditions should also be developed.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- case report
- left atrial appendage
- direct oral anticoagulants
- healthcare
- randomized controlled trial
- end stage renal disease
- venous thromboembolism
- heart failure
- primary care
- systematic review
- newly diagnosed
- percutaneous coronary intervention
- prognostic factors
- peritoneal dialysis
- bone marrow
- palliative care
- quality improvement
- decision making
- smoking cessation
- replacement therapy